Project Grant R43MD021438
- The National Institute for Minority Health and Health Disparities awarded Mae Health Inc. $303,389 on September 17, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and deploy a culturally-competent digital health platform integrated with doula community care networks for Black mothers enrolled in Medicaid. The platform tracks risk and symptoms personalized to the Black perinatal journey and coordinates care with services offered by managed care...
- The National Institute for Minority Health and Health Disparities awarded The University of Chicago $830,875 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and evaluate a primary care model addressing interconception care—healthcare services provided after pregnancy to support optimal outcomes in future pregnancies. The award supports research on how primary care providers can address treatable chronic diseases including diabetes,...
- The National Institute for Minority Health and Health Disparities, part of the National Institutes of Health under the Department of Health and Human Services, awarded ISA Associates, Inc. $918,009 on September 17, 2025, to develop a mobile intervention targeting the reduction of chronic stress impact on preterm birth risk in African American women. The award is a Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307). ISA Associates will deliver a mobile...
- The National Institute for Minority Health and Health Disparities awarded Michigan State University $1,269,874 on July 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to refine and test a patient-reported outcome measure (PROM) called Urgent Maternal Warning Signs for identifying severe maternal morbidity (SMM) in the postpartum period. The project addresses gaps in early detection of postpartum SMM, which accounts for approximately two-thirds of maternal...
- The National Institute for Minority Health and Health Disparities awarded Malama Health, Inc. $1.764 million on September 17, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a specialized risk-stratification platform and tailored diabetes prevention program for postpartum women with a history of gestational diabetes mellitus. The platform will address gaps in current remote monitoring technologies by incorporating contextual glucose information...
- The National Institute of Child Health and Human Development awarded Amahealth LLC $626,360 on September 17, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop an artificial intelligence method that predicts the timing of labor onset using physiological data from non-invasive wearable sensors. Over an eight-month period of performance ending October 31, 2026, Amahealth will enhance its existing work to interpret maternal vital sign patterns...
- The Department of Health and Human Services National Institute for Minority Health and Health Disparities awarded Collective Good DX, Inc. $349,322 on August 9, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a mobile peer-consult platform that leverages collective intelligence and adaptive machine learning to improve diagnostic accuracy in rural and underserved clinical settings. The platform will dynamically assess clinician expertise...
- The National Institute for Minority Health and Health Disparities awarded the University of Hawaii $644,528 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to measure the impact of a Native Hawaiian community-based birth preparation program on maternal health outcomes and prenatal care engagement. The recipient will conduct a quasi-experimental cohort study of Ka Lahui O Ka Po, an established, culturally grounded birth preparation program...
- The National Institute for Minority Health and Health Disparities awarded Datanomy Group LLC $306,801 on August 28, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop Project VELA, a cloud-based, model-agnostic federated query platform enabling multi-site research across health systems. Datanomy will build and validate a secure, federated query tool that allows researchers to ask clinically meaningful questions across diverse health systems without...
- The National Institute of Child Health and Human Development awarded the Regents of the University of Michigan $3.146 million on September 13, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to identify leading severe maternal morbidity indicators affecting deaf and hard of hearing women and develop a patient-informed obstetrical toolkit addressing clinical and health system factors that compound maternal health disparities. The research compares...
The National Institute for Minority Health and Health Disparities awarded Flourish Collective Inc. $306,798 under the Minority Health and Health Disparities Research program (CFDA 93.307) on August 9, 2026. Flourish Collective is developing an artificial intelligence–driven platform that predicts risk for poor maternal health outcomes and recommends action items to reduce that risk among pregnant women enrolled in Medicaid. The platform leverages data collected by doulas—non-clinical care workers with unprecedented access to patient familial, financial, and employment information—combined with clinician-collected data. Doulas will use the structured, data-informed framework to identify maternal health risks regardless of experience level and make timely recommendations to improve outcomes. The platform addresses the expansion of doula coverage across 43 state Medicaid programs and the resulting need to standardize risk identification and intervention guidance, particularly for pregnant women in the Medicaid system who represent nearly 41 percent of birthing mothers annually. The award supports Phase I research and development, with performance scheduled from August 9, 2026 through July 31, 2027, at Flourish Collective's location in Newport, Rhode Island.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $306.8k | 8/11/26 |